SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is drawing attention as traders position around the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the oncology pipeline, while skeptics warn that expectations and valuation are elevated and debate whether the event could prompt profit-taking.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is drawing attention, with traders attributing the move to possible short covering and technical buying rather than a confirmed new company announcement. The broader debate centers on upcoming DM1 and FSHD siRNA data: Novartis/Aviditys DM1 trial failure raised concerns about whether target knockdown can translate into patient benefit, while some traders argue Sareptas distinct delivery approach and the loss of a competitor could be favorable.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook drew attention as shares sold off despite strong demand, with traders frustrated by the reaction. The debate centers on whether higher costs, weaker cash generation and an insurance loss outweigh the stronger orders and guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic boost. Others question the deal because the divested unit contributes revenue, raising concerns about debt and the outlook for the remaining business; some traders are also taking profits after the surge.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Traders are focused on an expected FAA certification announcement for Boeings 737 MAX 10, a long-delayed milestone they see as potentially easing a key overhang. Reactions are divided: some expect the approval to improve sentiment and support future deliveries, while skeptics say it may be priced in and that production execution, delivery pace and cash generation matter more.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How to Find Strong Computer and Technology Stocks Slated for Positive Earnings Surprises

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

PLAB Investors Have Opportunity to Lead Photronics, Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Photronics, Inc. (Photronics or the Company) (NASDAQ: PLAB) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...

PLAB CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Photronics Investors of Securities Class Action Lawsuit Deadline on September 4, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Photronics, Inc. (Photronics or the Company) (NASDAQ: PLAB) and reminds investors of the September 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that...

Class Action Lawsuit Filed Against Photronics (PLAB): What Investors Need to Know by September 4 Lead Plaintiff Deadline

Class Action Lawsuit Filed Against Photronics (PLAB): What Investors Need to Know by September 4 Lead Plaintiff Deadline Class Action Lawsuit Filed Against Photronics (PLAB): What Investors Need to Know by September 4 Lead Plaintiff Deadline PR Newswire SAN FRANCISCO, Sept. 3, 2026 Hagens Berman...

Faruqi & Faruqi, LLP Urges Photronics, Inc. (NASDAQ: PLAB) Investors to Seek Counsel Before September 4, 2026 Lead Plaintiff Deadline in the Securities Class Action

Faruqi & Faruqi, LLP Urges Photronics, Inc. (NASDAQ: PLAB) Investors to Seek Counsel Before September 4, 2026 Lead Plaintiff Deadline in the Securities Class Action Faruqi & Faruqi, LLP Urges Photronics, Inc. (NASDAQ: PLAB) Investors to Seek Counsel Before September 4, 2026 Lead Plaintiff Deadline...

PLAB Deadline: PLAB Investors with Losses in Excess of $100K Have Opportunity to Lead Photronics, Inc. Securities Fraud Lawsuit

PLAB Deadline: PLAB Investors with Losses in Excess of $100K Have Opportunity to Lead Photronics, Inc. Securities Fraud Lawsuit PLAB Deadline: PLAB Investors with Losses in Excess of $100K Have Opportunity to Lead Photronics, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Sept. 2, 2026 NEW...

Photronics (PLAB) Securities Fraud Class Action Alert: PLAB Investors Face Sept. 4 Deadline - Hagens Berman

Hagens Berman alerts investors in Photronics, Inc. (NASDAQ: PLAB) to the September 4, 2026 lead plaintiff deadline in a class action claiming the company misled investors about demand and the outlook for its high-end integrated circuit (IC) photomask line.Submit Your Losses to Hagens BermanINVESTOR...

FRIDAY PLAB INVESTOR DEADLINE: Photronics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

FRIDAY PLAB INVESTOR DEADLINE: Photronics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit FRIDAY PLAB INVESTOR DEADLINE: Photronics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire SAN DIEGO, Aug. 31, 2026 SAN...

Photronics, Inc. Investor Alert: Contact SBS by September 4, 2026 for Opportunity to Lead Securities Fraud Lawsuit

Photronics, Inc. Investor Alert: Contact SBS by September 4, 2026 for Opportunity to Lead Securities Fraud Lawsuit Photronics, Inc. Investor Alert: Contact SBS by September 4, 2026 for Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS ANGELES, Aug. 31, 2026 LOS ANGELES, Aug. 31, 2026...

Photronics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PLAB

Photronics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PLAB Photronics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PLAB PR Newswire LOS ANGELES, Aug. 31, 2026 LOS ANGELES, Aug. 31, 2026 /PRNewswire...

Photronics, Inc. engages in the provision of photomasks, which are quartz or glass plates containing microscopic images of electronic circuits for use in the fabrication of integrated circuits and flat-panel displays. The company was founded by Constantine S. Macricostas in 1969 and is headquartered in Brookfield, CT.

Photronics, Inc.

Why Is PLAB Stock Rising Today?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Third-quarter revenue rose 2.7% year-over-year to $216 million compared to an estimated $208.75 million.</li><li>Adjusted earnings per share stood at $0.5 compared to the Street estimate of $0.4.</li><li>For the fourth quarter, the company expects revenue to be between $207 million and $227 million.</li></ul>Shares of Photronics Inc. (PLAB), a manufacturer of integrated circuit and flat panel display photomasks, surged in Wednesday’s premarket after the company reported upbeat third-quarter performance.&nbsp;CEO George Macricostas highlighted that the firm was able to recognize a recovery of some of the temporarily delayed semiconductor design releases that occurred during the fiscal second quarter.“Continued high fab utilization rates throughout the industry have been a positive influence toward node migration trends, resulting in a record percentage for our high-end I.C. business at 44% of total I.C. revenue. Our investments in the U.S. and Korea remain on track as we continue to strengthen our position at the high end of the market over the coming years,” said Macricostas.PLAB&nbsp;<a href="https://stocktwits.com/symbol/PLAB">stock</a> jumped over 21% in pre-market trade, and was on track to hit highs seen in May.<h2 class="st-heading-2">PLAB’s Q3 Report</h2>Third-quarter (Q3) revenue rose 2.7% year-over-year (YoY) to $216 million compared to an estimated $208.75 million. Adjusted earnings per share (EPS) stood at $0.5 compared to the Street estimate of $0.4.The firm’s IC revenue rose 5% YoY to $154.7 million while FPD revenue fell 2% to $61.4 million. Its cash, cash equivalents, and short-term investments at the end of the quarter totaled $672.8 million.For the fourth quarter, the company expects revenue to be between $207 million and $227 million. This compares with a consensus estimate of $215.68 million. The firm expects adjusted earnings per share attributable to shareholders to be between $0.40 and $0.56, compared with the Street estimate of $0.42.<h2 class="st-heading-2">How Retail Reacted To PLAB’s Earnings</h2>On Stocktwits, retail sentiment rose to ‘extremely bullish’ territory from ‘bullish’ a day ago, amid ‘high’ levels of retail chatter.One user said they expected a better earnings report.<stembedurl>https://stocktwits.com/Buckanator/message/662867461</stembedurl>Another user believes that the stock is still in recovery mode and that a rally might commence once it hits $45.<stembedurl>https://stocktwits.com/H_hi/message/662867296</stembedurl>PLAB shares have lost nearly 17% this year without taking into account Wednesday’s premarket movement.Also Read: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/mstr-stock-price-target-slashed-by-100-bernstein-pushes-bitcoin-150-k-forecast-to-2027/cZYNug3RJYS">MSTR Stock Price Target Slashed By $100, Bernstein Pushes Bitcoin $150K Forecast To 2027</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

CEO George Macricostas highlighted that the firm was able to recognize a recovery of some of the temporarily delayed semiconductor design releases that occurred during the fiscal second quarter.

Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

Vanguard Group, Inc. - Vanguard U.S. Momentum Factor ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$28.91
Prev Close	$28.35
Open	$27.83
Dividend Yield	0.00%
50-Day Moving Average	$29.87
Beta	2.08
Avg. Volume	963,838.97
PE Ratio	10.02

52-Week High	$56.00
52-Week Low	$20.05
Market Capitalization	$1.67B
EPS (Annual)	$2.28
Price to Book	1.29
Revenue Per Employee	$445,122.64

Feed

News

Sentiment

Earnings

Fundamentals

Info

PLAB Fundamentals